NEOS THERAPEUTICS INC - COM (NEOS)

CUSIP: 64052L106

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
6,195,229
Share change
+52,206
Total reported value
$88,378,117
Price per share
$14.32
Number of holders
44
Value change
-$4,696,044
Number of buys
28
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 64052L106?
CUSIP 64052L106 identifies NEOS - NEOS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOS THERAPEUTICS INC - COM (NEOS) as of Q4 2015

As of 31 Dec 2015, NEOS THERAPEUTICS INC - COM (NEOS) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,195,229 shares. The largest 10 holders included FRANKLIN RESOURCES INC, DSC Advisors, L.P., Sio Capital Management, LLC, DEERFIELD MANAGEMENT CO, EMERALD MUTUAL FUND ADVISERS TRUST, EMERALD ADVISERS INC/PA, BlackRock Fund Advisors, PUTNAM INVESTMENTS LLC, ADAGE CAPITAL PARTNERS GP LLC, and WALL STREET ASSOCIATES. This page lists 44 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.